 Heparin-induced thrombocytopenia patients open heart surgery heparin-dependent antiplatelet antibodies HAAb effect morbidity and/or mortality rates cases patients open heart surgery Forty-six patients HAAb patients groups patients HAAb surgery group patients HAAb surgery group II Group patients platelet-inhibiting drugs reexposure cardiopulmonary bypass strict abstinence heparin afterward platelet counts median Thromboembolic complications patients Group II patients HAAb surgery platelet-inhibiting drugs surgery Lowest platelet counts median complications patients thromboembolic complications patients Hospital mortality group II patients Late recognition HAAb increase morbidity mortality rates Thromboembolic complications HAAb surgery bleeding pretreatment platelet-inhibiting drugs strict abstinence heparin surgery